98%
921
2 minutes
20
Alexithymia, a major risk factor for a range of psychiatric and neurological disorders, has been recognized to comprise two dimensions, a cognitive dimension (difficulties identifying, analyzing, and verbalizing feelings) and an affective one (difficulties emotionalizing and fantasizing). Based on these dimensions, the existence of four distinct alexithymia subtypes has been proposed, but never empirically tested. In this study, 125 participants were assigned to four groups corresponding to the proposed alexithymia subtypes: Type I (impairment on both dimensions), Type II (impairment on the cognitive, but not the affective dimension), Type III (impairment on the affective, but not the cognitive dimension), and Lexithymics (no impairment on either dimension). By means of voxel-based morphometry, associations of the alexithymia dimensions and subtypes with gray and white matter volumes were analyzed. Type I and Type II alexithymia were characterized by gray matter volume reductions in the left amygdala and the thalamus. The cognitive dimension was further linked to volume reductions in the right amygdala, left posterior insula, precuneus, caudate, hippocampus, and parahippocampus. Type III alexithymia was marked by volume reduction in the MCC only, and the affective dimension was further characterized by larger sgACC volume. Moreover, individuals with the intermediate alexithymia Types II and III showed gray matter volume reductions in distinct regions, and had larger corpus callosum volumes compared to Lexithymics. These results substantiate the notion of a differential impact of the cognitive and affective alexithymia dimensions on brain morphology and provide evidence for separable neuroanatomical representations of the different alexithymia subtypes.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6869665 | PMC |
http://dx.doi.org/10.1002/hbm.22879 | DOI Listing |
BJPsych Open
September 2025
Medical Research Council Integrative Epidemiology Unit at the University of Bristol, Population Health Sciences, Bristol Medical School, Bristol, UK.
Background: Some psychotic experiences in the general population show associations with higher schizophrenia and other mental health-related polygenic risk scores (PRSs), but studies have not usually included interviewer-rated positive, negative and disorganised dimensions, which show distinct associations in clinical samples.
Aims: To investigate associations of these psychotic experience dimensions primarily with schizophrenia PRS and, secondarily, with other relevant PRSs.
Method: Avon Longitudinal Study of Parents and Children (ALSPAC) birth cohort participants were assessed for positive, negative and disorganised psychotic experience dimensions from interviews, and for self-rated negative symptoms, at 24 years of age.
Folia Med Cracov
December 2024
Center for Innovative Medical Education, Jagiellonian University Medical College, Kraków, Poland;
In contemporary medical practice, a reductionist focus on physical symptoms and biotechnological interventions often sidelines the relational and emotional dimensions of patient care. This paper explores the potential benefits of integrating phenomenological approaches into everyday healthcare practice. Drawing on the seminal works of Merleau-Ponty, Gallagher, Mazis, Benner, and Svenaeus, among others, the study illustrates how a phenomenological stance - characterized by a suspension of preconceptions and an embrace of "not-knowing" - can transform clinical encounters.
View Article and Find Full Text PDFBMC Psychol
September 2025
RISE-Health, Nursing School of Porto, Rua Dr. António Bernardino de Almeida 830/844/856, Porto, 4200-072, Portugal.
Background: Climate change and environmental degradation pose significant threats to ecosystems and human well-being, leading to increased eco-anxiety, especially among young adults. Eco-anxiety, characterized by worry and fear about environmental issues, can affect mental health and behaviours. This study aims to explore the relationships between eco-anxiety, sociodemographic factors, experiences of climate events, pro-environmental behaviours, and life satisfaction in young adults.
View Article and Find Full Text PDFBMC Cancer
August 2025
Research Department, Klinik Arlesheim, Arlesheim, Switzerland.
Background: Cancer-related fatigue is one of the most common symptoms in patients with cancer. Fatigue reduces health-related quality of life. The Cancer Fatigue Scale (CFS) is a brief instrument that captures the multidimensional nature of fatigue with robust validity.
View Article and Find Full Text PDFPharmaceuticals (Basel)
July 2025
Psychiatry, Medical School, Üsküdar University, 34662 İstanbul, Türkiye.
: Muscle dysmorphia (MD), a subtype of body dysmorphic disorder, is prevalent among males who engage in the non-medical use of anabolic-androgenic steroids (AASs) and performance-enhancing drugs (PEDs). These individuals often experience severe psychopathology, including mood instability, compulsivity, and a distorted body image. Despite its clinical severity, no randomized controlled trials (RCTs) have evaluated structured psychological treatments in this subgroup.
View Article and Find Full Text PDF